http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1094834-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0971c0301bb037954de6c6b6e286da9d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-31 |
| filingDate | 1999-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a973204c24ac9ea5a4b6e0f17c2f8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb2727cbdab422983aac62e2889841ec |
| publicationDate | 2003-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1094834-B1 |
| titleOfInvention | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| abstract | The use of a gastrointestinal peptide hormone, selected from glucagon-like peptide-1 (GLP-1) and its derivatives having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract, for the manufacture of a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome, is new. Independent claims are also included for the following: (1) a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome characterized in that it comprises a combination of at least one member selected from GLP-1 and its derivatives having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract with one or two more other gastrointestinal peptide hormone(s) and their derivatives having such effects and properties together with additives; and (2) a method for the treatment of functional dyspepsia or irritable bowel syndrome or both in a human patient, comprising administering the composition of (1). ACTIVITY : Anti-inflammatory. MECHANISM OF ACTION : GLP-1 is a gastrointestinal peptide hormone with antisecretory effects and smooth muscle relaxatory properties within the gastrointestinal tract. |
| priorityDate | 1998-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.